Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.
about
ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetLubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndromeLubiprostone targets prostanoid EP₄ receptors in ovine airways.Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.Direct interactions between ENaC gamma subunit and ClCN2 in cystic fibrosis epithelial cells.Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)).Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epitheliaCystic fibrosis and estrogens: a perfect stormLubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.Role of lubiprostone on gastrointestinal motility.Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series.Lubiprostone: clinical applications beyond constipation.Lubiprostone for constipation in adults with cystic fibrosis: a pilot study.Identification of the fatty acid activation site on human ClC-2.
P2860
Q28066092-4A563518-D366-4728-A05A-15C069B86363Q33693282-2F9D68C7-73FD-4F4F-B147-D8ACF1510DF5Q34345704-BDFC4981-A746-4749-AEEC-6E6EDAECE42DQ34540238-94960C9D-781E-4457-925E-1E6FCA45E1C3Q35216745-8CCB2EBA-2CE8-48A7-8A1F-E8EECB1D9B3DQ35294275-ABCDDD3F-9BA1-43A0-93FA-88A3C1628B1EQ36371798-60550941-51EF-4195-AC5B-2C16DB1B359BQ36699974-1DE63C8F-5F9F-41B4-AF4B-F4356CCCD5B7Q36972780-6DDD7BF0-DD2D-45A0-B016-4B7796C54771Q37190237-A3B2B4F0-3FCB-4F01-82AD-77550C630A54Q38029718-4DD50063-5441-4561-BE64-C9FDED2DE196Q39646395-E359ABD7-5E5F-48C8-9E8A-C5861CBA0CB9Q41811753-C3464050-7665-48DA-A5F3-8F12083385EEQ43152517-16D89714-62B9-4853-98EB-743EDA6E10FCQ43163697-C1A1E575-34FB-42FF-AD81-50072EC0716BQ46554243-6B38CD7B-31DE-4498-ABC8-EFA605C382CDQ50716076-DB5AE452-3908-4866-8334-FCDD5D2CD25C
P2860
Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Lubiprostone activates non-CFT ...... etion in cystic fibrosis mice.
@en
type
label
Lubiprostone activates non-CFT ...... etion in cystic fibrosis mice.
@en
prefLabel
Lubiprostone activates non-CFT ...... etion in cystic fibrosis mice.
@en
P2093
P2860
P1476
Lubiprostone activates non-CFT ...... retion in cystic fibrosis mice
@en
P2093
Charles E Hawkins
Karen R McKenzie
Kelvin D MacDonald
Mark J Henderson
Neeraj Vij
P2860
P304
P356
10.1152/AJPLUNG.90221.2008
P577
2008-09-19T00:00:00Z